Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

Share Price is delayed by 15 minutes
Get Live Data
2,018.00    12.00 (0.60%)
Bid:
2,026.00
Ask:
2,028.00
Spread: 2.00 (0.099%)
Market Cap: £2.24b
DLN Live PriceLast checked at - London Stock Exchange

Intraday Derwent London Share Chart

Board Change

12 Aug 2025 07:00

RNS Number : 8797U
Derwent London PLC
12 August 2025
 

Business Update12 August 2025

 

Derwent London plc ("Derwent London" / "the Company")

BOARD CHANGE

 

Derwent London announces that Nigel George, Executive Director, has informed the Board of his intention to retire and stand down from the Board on 31 March 2026. Nigel has been a Director of Derwent since 1998. 

Nigel will remain a full-time employee until August 2026 and following that we have asked Nigel to continue to support the business as a consultant working on a number of group projects until 2028.

During Nigel's tenure at Derwent London, he has been integral to the Group's investment acquisitions and disposals. Nigel has been involved with many of Derwent's major transactions including being a leading member of the team that secured the merger with LMS in 2007.

While Nigel will continue to work closely with Derwent London, the Board wishes to extend its gratitude to him for his dedication and service in developing the Derwent London brand and its reputation.

Paul Williams, Chief Executive of Derwent London, said:

"It has been a privilege to work alongside Nigel for his 37 years at Derwent and, on behalf of my fellow directors, I wish to thank him for his considerable contribution to the business. During that time Nigel has played an important role in the growth and success of the company with deep knowledge of Derwent and the London property market."

Nigel George, Executive Director, said:

"I would like to thank Paul and my fellow Directors, as well as all the people of Derwent, for their long-term support and encouragement as we have built this great business together. Over this time London has continually evolved and so have we, giving rise to many value creating opportunities. I am pleased that I will remain involved with the company as a consultant and look forward to supporting delivery of some exciting projects during the remainder of my time at Derwent."

Information equivalent to that required under section 430(2B) of the UK Companies Act 2006 will be made available on the Company's website at the time Nigel George steps down from the Board and in the Company's 2025 Directors' Remuneration Report.

 

For further information, please contact:

Derwent London

Tel: +44 (0)20 3478 4217 (Robert Duncan)

Mark Breuer, Chairman

Paul Williams, Chief Executive

Robert Duncan, Head of Investor Relations

 

Brunswick Group

Tel: +44 (0)20 7404 5959

Simon Sporborg

Nina Coad

 

Notes to editors

Derwent London plc

Derwent London plc owns a commercial real estate portfolio predominantly in central London valued at £5.2 billion as at 30 June 2025, making it the largest London office-focused real estate investment trust (REIT).

Our experienced team has a long track record of creating value throughout the property cycle by regenerating our buildings via redevelopment or refurbishment, effective asset management and capital recycling. We typically acquire central London properties off-market with low capital values and modest rents in improving locations, most of which are either in the West End or City Borders. We capitalise on the unique qualities of each of our properties - taking a fresh approach to the regeneration of every building with a focus on anticipating tenant requirements and an emphasis on design. Reflecting and supporting our long-term success, the business has a strong balance sheet with modest leverage, a robust income stream and flexible financing.

We are frequently recognised in industry awards for the quality, design and innovation of our projects. Landmark buildings in our 5.3 million sq ft portfolio include 1 Soho Place W1, 80 Charlotte Street W1, Brunel Building W2, White Collar Factory EC1, Angel Building EC1, 1-2 Stephen Street W1 and Tea Building E1.

As part of our commitment to lead the industry in mitigating climate change, Derwent London has committed to becoming a net zero carbon business by 2030, publishing its pathway to achieving this goal in July 2020. Our science-based carbon targets validated by the Science Based Targets initiative (SBTi). In 2013 the Company launched a voluntary Community Fund which has to date supported 180 community projects in central London.

The Company is a public limited company, which is listed on the London Stock Exchange and incorporated and domiciled in the UK. The address of its registered office is 25 Savile Row, London, W1S 2ER.

For further information see www.derwentlondon.com or follow us on LinkedIn

Forward-looking statements

This document contains certain forward-looking statements about the future outlook of Derwent London. By their nature, any statements about future outlook involve risk and uncertainty because they relate to events and depend on circumstances that may or may not occur in the future. Actual results, performance or outcomes may differ materially from any results, performance or outcomes expressed or implied by such forward-looking statements.

No representation or warranty is given in relation to any forward-looking statements made by Derwent London, including as to their completeness or accuracy. Derwent London does not undertake to update any forward-looking statements whether as a result of new information, future events or otherwise. Nothing in this announcement should be construed as a profit forecast.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPBMRTMTTBBBA
Date   Source Headline
2nd May 20193:00 pmRNSAdjustment to Conversion Price
2nd May 201912:03 pmRNSHolding(s) in Company
30th Apr 20194:30 pmRNSTotal Voting Rights
30th Apr 20194:00 pmRNSDirector/PDMR Shareholding
30th Apr 20197:00 amRNSFIRST OFFICE PRE-LET AT SOHO PLACE W1
25th Apr 20194:04 pmRNSHolding(s) in Company
23rd Apr 20199:00 amRNSBondholders' meeting
15th Apr 20191:00 pmRNSAnnual Report & Accounts 2018 and Notice of AGM
5th Apr 20194:30 pmRNSDirector/PDMR Shareholding
29th Mar 20193:00 pmRNSDirector Declaration
29th Mar 201911:00 amRNSTotal Voting Rights
28th Mar 20197:00 amRNSBrunel Building Office Space Fully Pre-Let
21st Mar 201911:00 amRNSDirector/PDMR Shareholding
20th Mar 20191:30 pmRNSBlock listing Interim Review
15th Mar 20193:00 pmRNSHolding(s) in Company
13th Mar 201910:30 amRNSDirector/PDMR Shareholding
12th Mar 201910:00 amRNSDirector/PDMR Shareholding
5th Mar 201910:30 amRNSAdditional Listing
28th Feb 20195:00 pmRNSTotal Voting Rights
27th Feb 20199:30 amRNSHolding(s) in Company
26th Feb 20195:00 pmRNSDividend Declaration
26th Feb 20197:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2018
18th Feb 20199:00 amRNSHolding(s) in Company
31st Jan 20194:30 pmRNSTotal Voting Rights
28th Dec 20183:00 pmRNSTotal Voting Rights
13th Dec 20185:00 pmRNSHolding(s) in Company
30th Nov 20181:00 pmRNSTotal Voting Rights
30th Nov 201810:00 amRNSInvestor and Analyst Presentation and Tour
23rd Nov 20187:00 amRNSDirectorate Change
22nd Nov 20187:00 amRNS£250 Million US Private Placement
8th Nov 20187:00 amRNSQ3 2018 Business Update
7th Nov 20183:00 pmRNSHolding(s) in Company
31st Oct 20183:00 pmRNSTotal Voting Rights
17th Oct 201811:00 amRNSAdditional Listing
8th Oct 20189:43 amRNSChange of Credit Rating Agency
4th Oct 20184:00 pmRNSHolding(s) in Company
28th Sep 201811:00 amRNSTotal Voting Rights
20th Sep 20183:00 pmRNSBlock listing Interim Review
12th Sep 20185:30 pmRNSDirector/PDMR Shareholding
31st Aug 20181:00 pmRNSTotal Voting Rights
30th Aug 201811:00 amRNSAdditional Listing
28th Aug 20184:00 pmRNSDirector/PDMR Shareholding
9th Aug 20187:00 amRNSDirectorate Change
9th Aug 20187:00 amRNSHalf-year Results
31st Jul 201811:00 amRNSTotal Voting Rights
30th Jul 201810:00 amRNSHolding(s) in Company
4th Jul 201810:00 amRNSAdditional Listing
2nd Jul 201812:00 pmRNSHolding(s) in Company
29th Jun 20185:00 pmRNSDirector/PDMR Shareholding
29th Jun 20184:30 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.